Ana Callejo

940 total citations
44 papers, 565 citations indexed

About

Ana Callejo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Ana Callejo has authored 44 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 11 papers in Immunology and Allergy. Recurrent topics in Ana Callejo's work include Cancer Immunotherapy and Biomarkers (12 papers), Lung Cancer Treatments and Mutations (11 papers) and Allergic Rhinitis and Sensitization (10 papers). Ana Callejo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Lung Cancer Treatments and Mutations (11 papers) and Allergic Rhinitis and Sensitization (10 papers). Ana Callejo collaborates with scholars based in Spain, Palestinian Territory and United States. Ana Callejo's co-authors include Alicia Armentia, Francisco Javier Martín Gil, M. Lombardero, José M. Vega, Pedro V. Castro-Martínez, Teresa Ramón y Cajal Asensio, Manuel Martín‐Esteban, Cristina Pascual, Patricia Iranzo and Domingo Barber and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Ana Callejo

41 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Callejo Spain 12 162 140 88 80 65 44 565
Tomás Chivato Spain 14 15 0.1× 275 2.0× 55 0.6× 59 0.7× 91 1.4× 24 528
Kaori Mukai Japan 14 98 0.6× 520 3.7× 109 1.2× 13 0.2× 88 1.4× 54 1.1k
Rosario Cabañas Spain 20 38 0.2× 221 1.6× 65 0.7× 228 2.9× 231 3.6× 65 1.3k
Pilar Palomino Spain 12 31 0.2× 191 1.4× 38 0.4× 28 0.3× 96 1.5× 19 576
T. Herrero Spain 15 17 0.1× 154 1.1× 34 0.4× 62 0.8× 170 2.6× 34 484
M. De Barrio Spain 12 19 0.1× 127 0.9× 23 0.3× 51 0.6× 198 3.0× 40 442
Michael Flanagan United States 14 65 0.4× 100 0.7× 92 1.0× 8 0.1× 38 0.6× 50 683
Maria Conceição Pereira Santos Portugal 15 22 0.1× 169 1.2× 41 0.5× 58 0.7× 122 1.9× 50 681
Sandra A.C. Perez Brazil 13 17 0.1× 107 0.8× 96 1.1× 13 0.2× 22 0.3× 22 789
Catherine Chung United States 14 217 1.3× 9 0.1× 62 0.7× 58 0.7× 157 2.4× 87 881

Countries citing papers authored by Ana Callejo

Since Specialization
Citations

This map shows the geographic impact of Ana Callejo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Callejo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Callejo more than expected).

Fields of papers citing papers by Ana Callejo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Callejo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Callejo. The network helps show where Ana Callejo may publish in the future.

Co-authorship network of co-authors of Ana Callejo

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Callejo. A scholar is included among the top collaborators of Ana Callejo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Callejo. Ana Callejo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riveiro‐Barciela, Mar, Ana Barreira‐Díaz, Ana Callejo, et al.. (2024). An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor‐induced liver injury. Alimentary Pharmacology & Therapeutics. 59(7). 865–876. 11 indexed citations
2.
Iranzo, Patricia, et al.. (2023). Risk factors for cancer-related cognitive impairment in breast and colorectal cancer patients who undergo chemotherapy. SHILAP Revista de lepidopterología. 46(2). 2 indexed citations
3.
Carbonell, Caterina, Joan Frigola, Núria Pardo, et al.. (2023). Dynamic changes in circulating tumor DNA assessed by shallow whole‐genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC. Molecular Oncology. 17(5). 779–791. 4 indexed citations
4.
Cedrés, S., Patricia Iranzo, Ana Callejo, et al.. (2023). Current State-of-the-Art Therapy for Malignant Pleural Mesothelioma and Future Options Centered on Immunotherapy. Cancers. 15(24). 5787–5787. 4 indexed citations
5.
Callejo, Ana, Eva Muñoz‐Couselo, Patricia Iranzo, et al.. (2023). A two-step algorithm avoids corticosteroids in two-thirds of cancer patients with severe immune-mediated hepatitis due to immune checkpoint inhibitors. Journal of Hepatology. 78. S375–S376. 3 indexed citations
6.
Mirallas, Oriol, Núria Pardo, Ana Callejo, et al.. (2022). Hepatic Rupture as the Initial Presentation of an EGFR-Mutated Lung Adenocarcinoma: A Case Report. Frontiers in Oncology. 12. 837630–837630.
7.
Frigola, Joan, Caterina Carbonell, Patricia Iranzo, et al.. (2022). High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC. Journal for ImmunoTherapy of Cancer. 10(4). e004197–e004197. 6 indexed citations
8.
Cedrés, S., Patricia Iranzo, Ana Callejo, et al.. (2021). Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort. Scientific Reports. 11(1). 21357–21357. 10 indexed citations
9.
Callejo, Ana, Joan Frigola, Patricia Iranzo, et al.. (2021). Interrelations between Patients’ Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients. Cancers. 13(13). 3249–3249. 9 indexed citations
10.
Cedrés, S., Santiago Ponce-Aix, Patricia Iranzo, et al.. (2020). Analysis of mismatch repair (MMR) proteins expression in a series of malignant pleural mesothelioma (MPM) patients. Clinical & Translational Oncology. 22(8). 1390–1398. 8 indexed citations
11.
Gonzalez, N. Saoudi, Patricia Iranzo, Ana Callejo, et al.. (2020). 1798P Carboplatin-paclitaxel (CP) chemotheraphy as salvage treatment for small cell lung cancer (SCLC): A real-world evidence analysis. Annals of Oncology. 31. S1041–S1041. 1 indexed citations
12.
Iranzo, Patricia, Ana Callejo, Alejandro Navarro, et al.. (2020). Immune checkpoint inhibitors (ICI) response in metastatic non-small cell lung cancer (NSCLC) patients with WNT pathway mutations (APC/CTNNB1).. Journal of Clinical Oncology. 38(15_suppl). e15137–e15137. 1 indexed citations
13.
Frigola, Joan, Alejandro Navarro, Caterina Carbonell, et al.. (2020). Molecular profiling of long‐term responders to immune checkpoint inhibitors in advanced non‐small cell lung cancer. Molecular Oncology. 15(4). 887–900. 27 indexed citations
14.
Braña, Irene, Ignacio Matos, María Vieito, et al.. (2020). 573P Efficacy of immunotherapy (IT) after prior immune checkpoint inhibitors (ICIs) exposure. Annals of Oncology. 31. S489–S490. 1 indexed citations
15.
Armentia, Alicia, et al.. (2004). Living in towers as risk factor of pollen allergy. Allergy. 59(3). 302–305. 7 indexed citations
16.
Armentia, Alicia, et al.. (2004). Occupational rhinitis to leek (Allium porrum). Allergy. 60(1). 132–133. 4 indexed citations
17.
Armentia, Alicia, et al.. (2004). Occupational Asthma Due to Grain PestsEurygasterandEphestia. Journal of Asthma. 41(1). 99–107. 24 indexed citations
18.
Callejo, Ana, et al.. (2002). A new pollen–fruit cross‐reactivity. Allergy. 57(11). 1088–1089. 6 indexed citations
19.
Armentia, Alicia, M. Lombardero, Ana Callejo, et al.. (2002). Is Lolium pollen from an urban environment more allergenic than rural pollen?. Allergologia et Immunopathologia. 30(4). 218–224. 43 indexed citations
20.
Callejo, Ana, Alicia Armentia, M. Lombardero, & Teresa Ramón y Cajal Asensio. (2001). Propolis, a new bee‐related allergen. Allergy. 56(6). 579–579. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomás Chivato Breakdown of academic impact, for papers by Kaori Mukai Breakdown of academic impact, for papers by Rosario Cabañas Breakdown of academic impact, for papers by Pilar Palomino Breakdown of academic impact, for papers by T. Herrero Breakdown of academic impact, for papers by M. De Barrio Breakdown of academic impact, for papers by Michael Flanagan Breakdown of academic impact, for papers by Maria Conceição Pereira Santos Breakdown of academic impact, for papers by Sandra A.C. Perez Breakdown of academic impact, for papers by Catherine Chung
Rankless by CCL
2026